500 SYNB1891, a bacterium engineered to produce a STING agonist, demonstrates target engagement in humans following intratumoral injection
Autor: | Filip Janku, Jason Luke, Sarina Piha-Paul, Karl Lewis, James Strauss, Mary Varterasian, Anna Sokolovska, Richard Riese, Michael Armstrong, Claire Verschraegen, Aoife Brennan |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
Druh dokumentu: | article |
ISSN: | 2051-1426 |
DOI: | 10.1136/jitc-2021-SITC2021.500 |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |